Publicaciones en colaboración con investigadores/as de Hospital Universitari de Tarragona Joan XXIII (9)

2022

  1. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

    Frontiers in Physiology, Vol. 12

2020

  1. Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction

    Revista Espanola de Cardiologia, Vol. 73, Núm. 7, pp. 561-568

  2. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164

2018

  1. Influence of sex and pregnancy on survival in patients admitted with heart failure: Data from a prospective multicenter registry

    Clinical Cardiology, Vol. 41, Núm. 7, pp. 924-930

2017

  1. Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure

    International Journal of Cardiology, Vol. 240, pp. 265-270

2015

  1. A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients: The Redin-SCORE

    European Journal of Heart Failure, Vol. 17, Núm. 8, pp. 818-827

2013

  1. Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure

    European Journal of Heart Failure, Vol. 15, Núm. 8, pp. 877-884

2007

  1. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials

    Journal of the American Medical Association, Vol. 297, Núm. 12, pp. 1332-1343